WheltonPKAppelLJSaccoRL. et al. Sodium, blood pressure, and cardiovascular disease: Further evidence supporting the American Heart Association sodium reduction recommendations. Circulation2012; 126: 2880–2889.
2.
WuCYosefNThalhamerT. et al. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature2013; 496: 513–517.
3.
KleinewietfeldMManzelATitzeJ. et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature2013; 496: 518–522.
4.
FarezMFFiolMPGaitanMI. et al. Sodium intake is associated with increased disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry2015; 86: 26–31.
5.
DyerAElliottPCheeD. et al. Urinary biochemical markers of dietary intake in the INTERSALT study. Am J Clin Nutr1997; 65: 1246S–1253S.
6.
BrownIJDyerARChanQ. et al. Estimating 24-hour urinary sodium excretion from casual urinary sodium concentrations in Western populations: The INTERSALT study. Am J Epidemiol2013; 177: 1180–1192.
7.
KapposLFreedmanMSPolmanCH. et al. Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: A 3-year follow-up analysis of the BENEFIT study. Lancet2007; 370: 389–397.
8.
BarkhofFPolmanCHRadueEW. et al. Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: Integrated 2-year results. Arch Neurol2007; 64: 1292–1298.
9.
KrementsovDNCaseLKHickeyWF. et al. Exacerbation of autoimmune neuroinflammation by dietary sodium is genetically controlled and sex specific. FASEB J2015; 29: 3446–3457.
